Combination of Remdesivir and Antibodies Didn’t Work Against COVID-19: Study The Epoch TimesHyperimmune immunoglobulin for hospitalised patients with COVID-19 (ITAC): a double-blind, placebo-controlled, phase 3, randomised trial The LancetCOVID-19: Highly concentrated antibody solution not effective treatment The Jerusalem PostNew trial tests the effectiveness of hyperimmune immunoglobulin for hospitalized COVID-19 patients News-Medical.NetHyperimmune intravenous immunoglobulin does not improve outcomes for adults hospitalized with COVID-19 National Institutes of HealthView Full Coverage on Google News

  • Resistance to COVID-19 drug detected in lab study
    The virus that causes COVID-19 can develop partial resistance to the antiviral drug remdesivir during infection of cultured cells in the laboratory by more than one mechanism.
    05/16/2022 - 10:13 am | View Link
  • More
  • News
    The agency “took two actions” to expand the use of Veklury, or remdesivir, to include pediatric patients who are 28 days and older, weigh at least 7 pounds, and have tested positive for COVID-19. The FDA approval is applicable to children who are hospitalized or have mild-to-moderate COVID-19 symptoms and are also at high risk of severe ...
    05/13/2022 - 9:26 am | View Website
  • More
Welcome to Wopular!

Welcome to Wopular

Wopular is an online newspaper rack, giving you a summary view of the top headlines from the top news sites.

Senh Duong (Founder)
Wopular, MWB, RottenTomatoes

Subscribe to Wopular's RSS Fan Wopular on Facebook Follow Wopular on Twitter Follow Wopular on Google Plus

MoviesWithButter : Our Sister Site

More Business News